Literature DB >> 813963

Serum concentration and elimination from serum of thioridazine in psychiatric patients.

R Axelsson, E Mårtensson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 813963

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  8 in total

Review 1.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

Authors:  G Nyberg; R Axelsson; E Mårtensson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

3.  Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patients.

Authors:  R Ohman; R Axelsson
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

4.  Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.

Authors:  F A Vanderheeren; R G Muusze
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

5.  Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.

Authors:  R Axelsson; E Mårtensson; C Alling
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

6.  Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.

Authors:  A Shvartsburd; V Nwokeafor; R C Smith
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 7.  Antipsychotics in older patients. A safety perspective.

Authors:  B G Pollock; B H Mulsant
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

8.  Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.

Authors:  B Wode-Helgodt; G Alfredsson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.